PMID: 8948313Nov 1, 1996Paper

Risks of ovulation-induction therapy in systemic lupus erythematosus

British Journal of Rheumatology
D L HuongP Godeau

Abstract

We report on four women with systemic lupus erythematosus who developed two types of complications after ovulation-induction therapy for primary or secondary infertility. Primary infertility was associated with endometriosis in one patient. Three had previously known systemic lupus erythematosus. All had inactive disease at onset of ovulation-induction therapy. Three patients developed symptoms consistent with moderate lupus flare a few weeks after the onset of ovulation-induction therapy. One patient developed inferior vena cava and unilateral left renal vein thrombosis. No patient became pregnant. A high oestrogen level induced by ovulation-induction therapy may explain the occurrence of lupus flare in patients with prior inactive lupus. All our patients had prior asymptomatic antiphospholipid antibodies. One patient developed a major thrombotic event. The presence of antiphospholipid antibodies increases the thrombotic risk related to ovulation-induction therapy. We conclude that ovulation-induction therapy should be restricted to patients with long-standing inactive systemic lupus erythematosus. A preventive increase of the corticosteroid dosage should be proposed in addition to heparin or antiaggregant therapy for those wi...Continue Reading

Citations

Feb 26, 2010·Clinical Reviews in Allergy & Immunology·Sara E Walker
Mar 10, 2001·La Revue de médecine interne·D L HuongJ C Piette
Jul 2, 2003·Journal of Clinical Pathology·C C Mok, C S Lau
Jun 16, 2001·International Immunopharmacology·D Verthelyi
Mar 1, 2006·Reumatología clinica·N Fernández-LlanioJ A Román-Ivorra
Jun 24, 2004·American Journal of Reproductive Immunology : AJRI·Eli GevaAmi Amit
Oct 4, 2005·La Revue de médecine interne·E ChauvetC Vela
Jun 4, 2002·Best Practice & Research. Clinical Rheumatology·Anca D Askanase, Jill P Buyon
Sep 14, 2014·La Revue de médecine interne·P OrquevauxN Costedoat-Chalumeau
Oct 26, 2016·Journal of Autoimmunity·Maria Grazia LazzaroniAngela Tincani
Jan 17, 2017·The Journal of Rheumatology·Pauline OrquevauxNathalie Costedoat-Chalumeau
Mar 4, 2005·Treatments in Endocrinology·Anca D Askanase
Oct 6, 1998·Scandinavian Journal of Rheumatology. Supplement·B WechslerJ C Piette
Aug 3, 2000·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·D MacutP Gligorović
Oct 6, 1998·Scandinavian Journal of Rheumatology. Supplement·G Ruiz-IrastorzaG R Hughes
Sep 1, 1999·Rheumatic Diseases Clinics of North America·G L Lautenbach, M Petri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
D MeirowJ G Schenker
British Medical Journal
© 2021 Meta ULC. All rights reserved